发明名称 Derivatives of p-guanidinobenzoic acid and pharmaceutical agents containing them as an active ingredient
摘要 A derivative of p-guanidinobenzoic acid of the general formula (IA): <IMAGE> (IA) wherein Y represents an oxygen atom or a sulfur atom and (a) when Y is an oxygen atom, (R1)m is selected from the group consisting of: 5-(4-guanidinobenzoyloxy)-3-methoxymethyl, 3,5-dicarboxy, 3,5-bis(isopropoxycarbonyl), 3,5-bistrifluoromethyl, 3-acetyl, 3,5-bis(N-ethylcarbamoyl), and 3,5-bis(N-propylcarbamoyl); (b) when Y is a sulfur atom, (R1)m is selected from the group consisting of: 2-methyl, 3-methyl, 4-fluoro, 2-chloro, 3-chloro, 2,5-dichloro 2,6-dichloro, 3,4-dichloro, 2-bromo, 2-methoxycarbonyl, and 4-(N,N-diethylaminosulfonyl); or an acid addition salt of said derivative. A method for the treatment or prevention of diseases induced by abnormal enhancing of degradation of proteins by the action of elastase in mammals subject to or suffering therefrom, including the step of administering an effective amount of a p-guanidinobenzoic acid as described herein, is also disclosed.
申请公布号 US5376655(A) 申请公布日期 1994.12.27
申请号 US19930070683 申请日期 1993.06.02
申请人 ONO PHARMACEUTICAL CO., LTD. 发明人 IMAKI, KATSUHIRO;ARAI, YOSHINOBU;OHNO, HIROYUKI
分类号 C07C279/18;C07C309/65;C07C309/66;C07C311/08;C07C311/29;C07C311/46;C07C329/10;C07D213/65;C07D213/75;C07D277/04;C07D277/22;C07D295/26;(IPC1-7):A61K31/535;A61K31/44;A61K31/21;C07C327/16 主分类号 C07C279/18
代理机构 代理人
主权项
地址